ExLibris header image
SFX Logo
Title: Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?
Source:

Frontiers in Microbiology [1664-302X] Williams, Huw yr:2010


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Elkins, M. "Timing of hypertonic saline inhalation for cystic fibrosis." Cochrane database of systematic reviews 2.2 (2012). Link to Full Text for this item Link to SFX for this item
2. Bye, D. "The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study." The European respiratory journal 14.3 (1999): 678-85. Link to SFX for this item
3. Minasian, C. "Mannitol as a mucolytic in cystic fibrosis." Journal of the Royal Society of Medicine 100.47 (2007): 53-6. Link to Full Text for this item Link to SFX for this item
4. Lands, Larry C. "Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis." Cochrane Database of Systematic Reviews 6.6 (2013). Link to Full Text for this item Link to SFX for this item
5. Jonathan, Girish I. "Pharmacologic Agents for Mucus Clearance in Bronchiectasis." Clinics in chest medicine 33.2 (2012): 363-370. Link to SFX for this item
6. Reeves, Emer P. "The facilitating effect of hypertonic saline on resolution of airway inflammation in cystic fibrosis." American journal of respiratory and critical care medicine 185.2 (2012): 226-227. Link to SFX for this item
7. Vecellio, L. "Influence of realistic airflow rate on aerosol generation by nebulizers." International Journal of Pharmaceutics 371.1-2 (2009): 99-105. Link to SFX for this item
8. Daviskas, E. "Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum." Respirology 10.1 (2004): 46-56. Link to Full Text for this item Link to SFX for this item
9. Dauletbaev, N. "Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients." The European respiratory journal 14.5 (1999): 1150-1155. Link to SFX for this item
10. Houtmeyers, E. "Effects of drugs on mucus clearance." The European respiratory journal 14.2 (1999): 452-67. Link to SFX for this item
11. Ballmann, M. "Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis." Journal of cystic fibrosis 1.1 (2002): 35-37. Link to SFX for this item
12. Elkins, Mark R R. "A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis." The New England journal of medicine 354.3: 229-240. Link to SFX for this item
13. Donaldson, Scott H. "Mucus clearance and lung function in cystic fibrosis with hypertonic saline." The New England journal of medicine 354.3 (2006): 241-250. Link to SFX for this item
14. Flume, Patrick A A. "Cystic fibrosis pulmonary guidelines: Chronic medications for maintenance of lung health." American journal of respiratory and critical care medicine 176.10 (2007): 957-69. Link to SFX for this item
15. Suri, R. "Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis." American Journal of Respiratory and Critical Care Medicine 166.3 (2002): 352-5. Link to SFX for this item
16. Kunzelmann, K. "Pharmacotherapy of the ion transport defect in cystic fibrosis." Clinical and experimental pharmacology & physiology 28.11 (2001): 857-67. Link to Full Text for this item Link to SFX for this item
17. Marshall, B. "Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis." American journal of respiratory and critical care medicine 172.8 (2005): 1008-1012. Link to SFX for this item
18. Wohl, M E J. "Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group." New England Journal of Medicine, The 331.10 (1994): 637-42. Link to SFX for this item
19. Aurora, P. "Lung transplantation for cystic fibrosis." Journal of the Royal Society of Medicine 100.47 (2007): 46-52. Link to Full Text for this item Link to SFX for this item
20. Lees, B. "A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis." Health technology assessment 6.34 (2002): 1-60. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.